| Application no. and date | 13808043.7 (espacenet) (Federated) (European Patent Register), 20131218 | | Patent/reg. no. and date | DK/EP 2934582, 20191127 | | Publication date | 20151028 | | Priority no. and date | US 201261745293 P, 20121221 | | EP pub. no. and date |
EP 2934582 20151028 | | Effective date | | | Applicant/owner | Ichnos Sciences SA, Chemin de la Combeta, 5
2300 La Chaux-de-Fonds, CH | | Applicant ref. no. | BBS137028EPDK | | Inventor | ALBANESE, Jonathan André, c/o Glenmark Pharmaceuticals S.A.
Chemin de la Combeta 5
CH-2300 La Chaux-de-Fonds, CH,
GIOVANNINI, Roberto Pier-Lorenzo, c/o Glenmark Pharmaceuticals S.A.
Chemin de la Combeta 5
CH-2300 La Chaux-de-Fonds, CH,
O'MAHONY, Kevin Niall, c/o Glenmark Pharmaceuticals S.A.
Chemin de la Combeta 5
CH-2300 La Chaux-de-Fonds, CH | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/32 (2006.01) | | Title | ANTI-HER2-ANTISTOFFORMULERING | | Int. application no. | EP2013077166 | | Int. publication no. | WO2014096051 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
